by Inari | May 21, 2018 | News
IRVINE, CALIFORNIA – May 21, 2018 – Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism (“PE”). This clearance makes the FlowTriever System the first and only thrombectomy device cleared...
by Inari | Apr 30, 2018 | News
Multicenter FLARE Study for PE Treatment IRVINE, CALIFORNIA – April 27, 2018 – Inari Medical, Inc., announced today the presentation of results from its FlowTriever Pulmonary Embolectomy (“FLARE”) Clinical Study that evaluated the safety and effectiveness of the...
by Inari | Mar 30, 2018 | News
IRVINE, Calif., March 29, 2018 /PRNewswire/ — Inari Medical, Inc., announced today the close of a Series C financing totaling $27.0 million. The financing was led by new investor Gilde Healthcare and was joined by all of Inari’s existing investors...
by Inari | Oct 24, 2017 | News
IRVINE, CALIFORNIA – October 19, 2017 – Inari Medical, Inc., a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the treatment of venous thromboembolism (“VTE”), announced today it has...
by Inari | Apr 10, 2017 | News
IRVINE, CALIFORNIA – April 10, 2017 – Inari Medical Inc., a venture capital backed medical device company focused on the interventional treatment of venous thrombus, announced the treatment of the first patient with its ClotTriever Thrombectomy System. The ClotTriever...
by Inari | Mar 7, 2016 | News
IRVINE, CALIFORNIA – March 8, 2016 – Inari Medical, Inc. announced today that it has received an Investigational Device Exemption (“IDE”) for a study to evaluate the safety and effectiveness of the FlowTriever Retrieval/Aspiration System. Ken Rosenfield,...
